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Thrombotic microangiopathy associated with the hypere-
osinophilic syndrome.
Background. Hypereosinophilic syndrome (HES), defined as
persistent marked eosinophilia of unknown origin complicated
by end organ damage, is thought to be due to activation of
eosinophils and release of substances that are toxic to various
cells and tissues. An association between hypereosinophilia and
kidney damage is not well documented.
Methods. We describe two patients with the HES, acute renal
failure, and thrombocytopenic hemolytic anemia. Renal biopsy
pathology and immunohistochemistry for activated eosinophils
were performed.
Results. Renal biopsy revealed glomerular thrombosis,
proliferative arteritis, and glomerular and tubulointersti-
tial eosinophil infiltrates. Ultrastructurally, subendothelial
glomerular fibrin deposits and numerous luminal platelets
characteristic of thrombotic microangiopathy (TMA) were
present. Abundant degranulated eosinophils were localized in
glomeruli and the interstitium. Immunofluorescence with spe-
cific antibody to eosinophil granule major basic protein (MBP)
showed striking extracellular MBP deposition within glomeruli,
a marker of eosinophil degranulation. Both patients developed
TMA. High-dose glucocorticoids achieved sustained decrease
of blood eosinophils and improvement of renal function.
Conclusion. To our knowledge these are the first documented
cases of TMA associated with HES. We propose that products
released from degranulated eosinophils caused endothelial in-
jury and microvascular thrombosis. Recognition of this serious
renal complication associated with blood eosinophilia should
prompt early diagnosis and treatment.
Thrombotic microangiopathy (TMA) is a vasculopa-
thy associated with thrombocytopenia and microan-
giopathic hemolytic anemia. The central pathogenic
mechanism is endothelial injury secondary to various
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agents, including bacterial toxins, viruses, and endothe-
lial shear stress [1]. The most common examples of TMA
are diarrhea-associated hemolytic uremic syndrome and
thrombotic thrombocytopenic purpura. [2] Eosinophil-
associated syndromes are not associated with either
thrombotic thrombocytopenic purpura or hemolytic ure-
mic syndrome–induced kidney damage. For example, the
hypereosinophilic syndrome (HES) most commonly in-
volves the heart, lungs, nervous system, and skin and
neither the hemolytic uremic syndrome nor thrombotic
thrombocytopenic purpura has been reported with HES
[3].
We describe two HES patients who developed acute
renal failure, showed clinical and laboratory findings of
hemolytic uremic syndrome and thrombotic thrombocy-
topenic purpura, and had findings of TMA with evidence
of degranulated eosinophils in the renal biopsy. We pro-
pose that cytopathic effectors released by degranulated
eosinophils led to endothelial injury and TMA in the re-
nal microvasculature. To our knowledge this is the first
report of renal TMA associated with isolated hypere-
osinophilia.
CASE REPORTS
Patient 1
A 15-year-old African American boy presented with
headaches. He denied fevers, rashes, or gastrointestinal
complaints, and physical examination was unremarkable.
Leukocyte count was 40,200/lL with 80% eosinophils.
Serology for ascaris, toxocara, trichinella and strongy-
loides were negative; stool ova and parasites were ab-
sent. Chest x-ray films were normal. Over the period
of 1 week he developed fatigue, malaise, abdominal
pain, chills, fever, decreased urine output, jaundice, di-
arrhea, and vomiting. His past medical history was no-
table for seasonal allergic rhinitis but not asthma. His
medications were methylphenidate for attention deficit
hyperactivity disorder and antihistamines. He was
hospitalized and physical examination revealed an
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Table 1. Laboratory data on hospitalization
Variable Normal values Patient 1 Patient 2
Hemoglobin g/dL 13.8–17.2 9.8 13.3
Erythocyte sedimentation rate mm/hour 0–20 8 14
White blood cells per lL 3.8–9.8 23.7 × 103 14.7 × 03
Differential count%
Neutrophils 33–70 35 46
Lymphocytes 21–55 12 18
Eosinophils <16 years 2–12, >17 years 0–6 47 34
Monocytes 3–13 3 3
Platelets per mL 140-440 × 103/lL 76 × 103 101 × 103
Reticulocyte count% 0.5–1.5 2.8 2.32
Partial thromboplastin time seconds 23–34 27.5 29.7
Prothrombin time seconds 11–14 15.3 14.5
Coombs Positive Negative
Serum creatinine mg/dL 0.2–1.2 10.9 2.2
Blood urea nitrogen mg/dL 9–18 83 22
Serum protein g/dL 6.5–8 8 7.4
Albumin g/dL 3.6–5.0 3.6 4.1
Alkaline phosphatase U/L 70–260 303 123
Aspartate aminotransferase U/L 10–40 496 17
Alanine aminotransferase U/L 10–55 354 21
Lactate dehydrogenase U/L 300–750 15,190 Not done
Total bilirubin mg/dL 0.1–1.3 5.3 0.6
Carbon dioxide mmol/L 20–28 22 27
Sodium mmol/L 135–145 Normal Normal
Potassium mmol/L 3.3–4.9 5.9 Normal
Chloride mmol/L 97–110 Normal Normal
C3 mg/dL 83–185 91 Normal
C4 mg/dL 12–54 Normal Normal
Cryoglobulins Not done Negative
Allele-specific oligonucleotide IU/mL Not done 195
Human immunodeficiency virus Not done Negative
Hepatitis B surface antigen Positive Negative
Hepatitis C Negative Negative
Antineutrophil cytoplasmic antibody Negative Negative
Antiglomerular basement membrane Negative Negative
Antiphospholipid antibody Negative Negative
Serum IgG mg/dL 700–1450 1480 Not done
Serum IgE mg/dL 6.1–965 1670 47
Serum IgA mg/dL 60–33 Normal Not done
Serum IgM mg/dL 40–110 Normal Not done
Urine 3+protein 3+ protein
3+blood 7 eosinophils
ill-appearing jaundiced boy with scleral icterus. He was
afebrile and normotensive, with normal cardiovascular
and pulmonary examinations. His abdomen was mildly
tender throughout, without organomegaly or masses.
White cell count was 23,700/lL with 47% eosinophils.
Hemoglobin was 9.8 mg/dL, platelets 76,000/lL, lac-
tate dehydrogenase (LDH) 15,190 U/L, blood urea ni-
trogen (BUN) 83 mg/dL, and creatinine 10.9 mg/dL.
Additional laboratory tests (Table 1) showed increased
alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), and alkaline phosphatase. Total biliru-
bin was 5.3 mg/dL with 1.2 conjugated (range 0 to 0.3
mg/dL). Serum IgG and IgE were elevated. Electrolytes
were normal except for potassium 5.9 mmol/L. Urinal-
ysis showed >50 red blood cells/high power field, and
3+ albumin. Prothrombin time was mildly prolonged,
partial thromboplastin time was normal, fibrin degra-
dation products (FDP) were >40 lg/mL (normal <10
lg/mL) and fibrinogen was 262 mg/dL (normal 200 to
400mg/dL). The Coombs test (direct and indirect) was
positive. Antineutrophil antibody (ANA), antineutrophil
cytoplasmic antibody (ANCA) and antiphospholipid an-
tibodies were absent; antidouble-stranded DNA was low
positive at 39.5 U; antiextractable nuclear antigen (ENA)
screen was negative; glomerular basement antibodies
were negative; complement, C3, C4 and CH50 were low-
borderline (measured after plasmapheresis); hepatitis B
surface antigen was positive; hepatitis A and C antibod-
ies were not detected. Blood and urine cultures were
negative. A chest x-ray film was normal, and ultrasound
showed mild ascites and echogenic renal cortices.
The laboratory tests were consistent with acute re-
nal failure and hemolytic anemia. The patient was
anuric despite aggressive hydration and transfusion.
He became hypertensive and developed pulmonary
edema. Hemodialysis and prednisolone 1.0 g daily treat-
ments were given, and eosinophilia resolved within 48
hours. He received intravenous immunoglobulin and
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cyclophosphamide for acute hemolysis, and plasma-
pheresis for worsening thrombocytopenia. Hemolysis
persisted despite therapy, and rituximab (anti-CD20
monoclonal antibody) was started with resolution of
hemolysis. Erythropoietin was also begun. After 14 days
of anuria, some renal function returned, although serum
creatinine remained greater than 3 mg/dL.
Bone marrow biopsy showed increased cellularity and
80% of the cells were eosinophils and eosinophilic precur-
sors. Renal biopsy contained fifteen glomeruli. One was
globally sclerosed. Six glomeruli showed global mesangi-
olysis and or thrombosis of afferent arterioles (Fig. 1A).
Small epithelial crescents were present in an additional
three glomeruli (20%). The interstitium, tubules and
glomeruli showed a predominantly eosinophilic infiltrate.
Notably, many eosinophils were degranulated (Fig. 1B).
There was no evidence of interstitial fibrosis. Routine im-
munofluorescence was negative for IgG, IgA, IgM, C3,
C4, C1q, albumin and j and k chain deposits. Fibrinogen
deposits were focally positive within thrombosed arteri-
oles (Fig. 1E). Electron microscopy demonstrated focal
fusion of podocyte foot processes, degenerated and de-
tached podocytes, and fused and edematous endothelial
cells. Subendothelial “fluffy” deposits and subendothe-
lial and luminal fibrin deposits were present and are
characteristic of TMA (Fig. 1C) [4]. Immunoglobulin-
type electron-dense deposits were absent. Numerous
eosinophils were present in the glomeruli (Fig. 1D) and
capillary lumens were filled with platelets and schis-
tocytes. Eosinophils were degenerated with numerous
granules showing loose crystals within the glomerular
mesangium (Fig. 1D, arrowheads). Immunofluorescence
demonstrated striking major basic protein (MBP) depo-
sition within all glomeruli and focally in small arterioles
(Fig. 1F). A diagnosis of TMA associated with idiopathic
HES was made.
The patient was discharged 1 month after admission
on a regimen of cyclophosphamide, interferon-a, ery-
thropoietin, furosemide, clonidine, diltiazem, septra pro-
phylaxis, prednisone, and weekly rituximab infusions to
complete a four-infusion course. Six months after dis-
charge, his renal function remained stable. However,
he developed relative eosinophilia when the prednisone
dose was reduced below 10 mg/day, although this abnor-
mality rapidly normalized following an increase in pred-
nisone. At a recent clinic visit, creatinine was 5.2 mg/dL.
He is currently on prednisone (20 mg/day), interferon-
a, furosemide, clonidine, and epoetin for chronic renal
failure and hypertension.
Patient 2
A 26-year-old white male complained of headaches and
progressive sensory and motor deficits. Four months ear-
lier, he injured his head, but he did not lose consciousness.
Three months earlier, he sustained another accident and
noticed headaches, and progressive blurring of the vision
in his right eye with photophobia. He also described clum-
siness of his right hand with deterioration in his handwrit-
ing and numbness in his left lower leg. One month prior
to admission a magnetic resonance imaging (MRI) scan
of the brain showed laminar necrosis in multiple vascular
distributions consistent with strokes. Lumbar puncture
revealed mildly elevated protein. Repeat MRI scan of
the brain 3 months later did not show progression of the
previously described lesions. He was incidentally noted
to have an absolute eosinophilia and elevated serum
creatinine (2.2 mg/dL) with nephrotic range proteinuria
(84 mg/dL). He had been taking several pain medica-
tions (acetaminophen and propoxephene) antihyperten-
sives, including a b blocker (atenol) and a calcium chan-
nel blocker (amlodipine), antiemetics (hydrocodone and
trimethobenzamide metoclopramide), antibiotics (ceftri-
axone) and an antiepileptic (zonisamide).
He was hospitalized for further evaluation and on
admission was normotensive and afebrile. Abnormali-
ties included pronator weakness on the right with mild
impairment of fine finger movements, reduced light
touch sensation in the left lower extremity, and diffi-
culty with tandem gait. Retinal vasculitis with neovas-
cularization of the right iris and neovascular acute angle
glaucoma were present. Leukocytes were increased and
the platelet count was in the low normal range. Periph-
eral blood smear showed 34%, eosinophils, three schisto-
cytes, and spherocytes per high power field. Reticulocyte
count was increased. Prothrombin time was slightly pro-
longed, partial thromboplastin time was normal. Coombs
test was negative. Urinalysis showed 3+ protein, seven
eosinophils/per high power field, and 3440 mg of pro-
tein/24 hours with a measured creatinine clearance of
57.2 mL/min. Laboratory data are summarized in Table 1.
Renal ultrasound confirmed the presence of two normal
sized kidneys, and a chest radiogram was normal. By day
2 of admission platelets decreased to 101 × 103 and FDP
were >40 lg/mL (expected <10 lg/mL). A diagnosis of
HES was made on the basis of persistent eosinophilia, ab-
sence of any other identifiable cause for the eosinophilia,
and the presence of multiple end organ damage.
Bone marrow biopsy showed hypercellular mar-
row with 44% eosinophils. Renal biopsy contained 25
glomeruli; none was globally or segmentally sclerosed
and crescents were absent. Two glomeruli showed pro-
liferative arteriopathy in small arterioles associated with
thrombosis (Fig. 2A). Five additional glomeruli had
capillary thrombosis for a total of 28% thrombosed
glomeruli. The interstitium showed mild fibrosis and
mild chronic inflammation with prominent eosinophil
infiltration, many of which appeared degranulated. Fo-
cally, eosinophils filled tubular lumens forming tight
white cell casts. Vital red histochemistry (a stain that
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Fig. 1. Renal biopsy findings in patient 1.
(A) Hemorrhagic glomerulus with mesan-
giolysis (hematoxylin and eosin ×40). (B)
Glomerulus with numerous eosinophils (ar-
rowheads) (hematoxylin and eosin ×40). (C)
Electron microscopy shows subendothelial
irregularly shaped deposits consistent with
fibrin deposits. A schistocyte (∗) is present
in the capillary lumen (×10,000). (D) Elec-
tron microscopy shows loose eosinophil gran-
ules with prominent and characteristic crys-
tal cores within the glomerular mesangium
(×10,000). (E) Immunofluorescence. Fibrino-
gen deposits within arterial thrombus (×60).
(F) Major basic protein (MBP) immunoflu-
orescence shows extensive, bright extracellu-
lar MBP deposition on the glomerular mem-
branes and on an adjacent afferent arteriole
deposits (×40).
A B
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Fig. 2. Renal biopsy findings in patient 2. (A)
Proliferative arteritis in afferent arteriole (∗)
(hematoxylin and eosin ×40). (B) Tubular
eosinophil casts. Vital Red stain highlights the
cytoplasm and loose granules of eosinophils
(×20). (C) Fibrinogen deposits in glomerulus
(immunofluorescence ×60). (D) Positive ex-
tracellular major basic protein (MBP) depo-
sition within a glomerulus and afferent arteri-
ole. The MBP strikingly outlines the glomeru-
lar membranes and an adjacent afferent arte-
riole (immunofluorescence ×40). (E) Nega-
tive control. Parallel sections stained with nor-
mal rabbit IgG (immunofluorescence ×40).
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highlights eosinophil cytoplasm and granules) confirmed
exclusively eosinophilic tubular casts and revealed foci of
loose red granules of degranulated eosinophils (Fig. 2B).
Routine immunofluorescence was negative for immune
complex deposits. Fibrinogen was positive in some
glomeruli (Fig. 2C). Electron microscopy showed mul-
tifocal effacement of foot processes, partial glomerular
basement membrane (GBM) thickening and wrinkling
and prominent podocytes consistent with proteinuria.
Importantly, subendothelial widening and fibrin deposits
were evident. These findings were consistent with TMA.
Immunofluorescence with antibody to MBP showed in-
tense staining in all glomeruli and some small arterioles;
in contrast, parallel sections stained with normal rabbit
IgG (negative control) were negative (Fig. 2D and E).
The patient was treated with intravenous methylpred-
nisolone 1 g per day for 3 days and then oral prednisone
80 mg/day. His leukocyte count decreased to 11,400/lL
with normal eosinophils (6%), and his renal function im-
proved with a serum creatinine of 1.7 mg/dL and a urine
protein to creatinine ratio of 1.8. The patient was started
on imatinib. A year later, despite blindness in the right
eye, overall his condition remains stable with a white
cell count of 11,900 lL, normal (5%) peripheral blood
eosinophils and a serum creatinine of 1.8 mg/dL.
DISCUSSION
HES is characterized by marked (>1500 × 106/L) and
prolonged (>6 months) eosinophilia with end organ in-
volvement in the absence of known eosinophil-associated
diseases [1]. Both patients satisfied these criteria, both
developed renal failure and subsequent renal biopsies
showed TMA. Kidney disease is thought to be rare in
HES [3]. In previously reported HES cases, renal pathol-
ogy is either poorly described, or nonspecific [5–7]. One
report noted that as many as one in five HES patients de-
velops proteinuria and hypertension [8]. However, most
such patients present late in the course of the HES and
likely have ischemic renal changes secondary to throm-
boembolism from endomyocardial disease [3, 7–9]. An-
other cause of renal disease associated with increased
blood eosinophils is atheroembolism [10]. This compli-
cation has been reported in elderly patients with ad-
vanced atherosclerosis, associated thrombocytopenia and
low serum complement. Frequently, atheroembolism fol-
lows abdominal or renal arterial surgery [10]. However,
it should be emphasized that atheroembolism-associated
hypereosinophilia is not part of the HES; eosinophilia
is incidental and not required to make the diagnosis of
atheroembolism. HES is also associated with crescentic,
and immunotactoid glomerulonephritis [11, 12] (summa-
rized in Table 2) with IgG, IgM, IgA, and C3 glomeru-
lar deposits in some cases, while in others, similar to the
patients described here, with absent immune deposits
Table 2. Hypereosinophilia and kidney disease
Histopathologic findings Reference
Thromboembolism Spry [3], Date et al [9]
Atheroembolism Giudicelli et al [6],
Wilson et al [10]
Ischemic changes Motellon et al [7]
Interstitial nephritis Bulucu et al [5]
Crescentic glomerulonephritis Richardson et al [11]
Immunotactoid glomerulonephritis Choi et al [12]
Thrombotic microangiopathy Liapis et al (current report)
[5]. Interestingly, while a relationship between HES and
thrombosis has been recognized, an association of hyper-
eosinophilia with renal TMA is not established.
The differential diagnosis based on light microscopic
findings in the renal biopsy of both patients included
TMA and small vessel vasculitis, particularly ANCA-
negative Churg-Strauss syndrome, especially in the pres-
ence of some glomerular crescents associated with
hypereosinophilia. Churg-Strauss syndrome is typically
associated with asthma and when the kidney is involved,
patients usually present with acute renal failure and cres-
centic glomerulonephritis [13]. Even though TMA is not
part of the vasculitides according to the criteria of the now
generally accepted Chapel Hill Concensus Conference,
crescents do not exclude TMA [14]. In fact, crescents in-
volving <30% of the glomeruli may be seen in 5.6% of
cases with TMA [14]. Both patients had characteristic
histopathologic findings of TMA with fibrin thrombi in
glomerular capillaries or small arterioles. Other causes
of TMA [2], such as antiphospolipid syndrome were ex-
cluded in both patients.
In HES, patients are thought to have increased ac-
tivated blood eosinophils. Once activated, eosinophils
release a number of cytopathic substances, especially
granule proteins [15]. MBP is toxic to a variety of cells,
including endothelial, intestinal, and airway epithelium.
MBP and eosinophil cationic protein (ECP) are thought
to act by damaging lipid bilayers. In addition, MBP is a
potent stimulator of platelets, binds to thrombomodulin
and reduces its ability to inhibit the clotting cascade [15,
16]. Eosinophils also produce other mediators, includ-
ing reactive oxygen species, leukotrienes, prostaglandins,
platelet-activating factor, cytokines, and matrix-digesting
enzymes [15, 17]. The results in our patients suggest that
MBP and other granule proteins injured the endothelium
and may have promoted thrombosis by altering the clot-
ting system and activating platelets. Thus, it is easy to
envision that the vascular endothelial damage central to
forming microthrombi is mediated by eosinophils. Nor-
mal kidney is devoid of eosinophils [17]. Specific extra-
cellular MBP staining is taken as evidence of eosinophil
degranulation. These findings emphasize the importance
of prompt treatment for patients with hypereosinophilia
and renal dysfunction. In both these patients, renal
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function improved after the administration of corticos-
teroids and resolution of the peripheral eosinophilia.
However, because such an association is not documented,
significant time elapsed between evaluation and therapy.
Overall, our results suggest that activated eosinophils
mediated renal injury and TMA in both patients. The re-
nal biopsy findings in the two patients are similar, though
not identical. However, TMA is an entity with a spec-
trum of histopathologic findings [2]. To our knowledge
these are the first documented cases of idiopathic hyper-
eosinophilia associated with renal TMA.
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